Background: Transcriptional networks in mouse trophoblast stem cells differentiation are not fully characterized. Results: Changes in Sox21 gene expression modulate lineage-specific markers during trophoblast stem cell differentiation. Conclusion: The expression levels of Sox21 need to be tightly regulated to achieve the right balance of terminally differentiated trophoblast cells. Significance: This is the first study showing expression and function of Sox21 in mouse placenta and trophoblast stem cells.
The epithelial compartment of the mammalian placenta is generated from trophoblast stem cells (TSCs), 2 a self-renewing population of cells that in the mouse can be derived from either the blastocyst polar trophectoderm or the extraembryonic ectoderm up to E8.5 (1, 2) . During placentation, precursor cells exit the cell cycle, down-regulate stem cell markers, and undergo terminal differentiation. Although progress has been made in defining genes and signaling pathways that regulate this process, the molecular mechanisms that prompt TSCs to initiate programs of trophoblast differentiation are incom-pletely defined. In the mouse embryo, FGF4 produced in vivo by the inner cell mass supports the self-renewal of TSCs (1) . In addition to FGF4, members of the TGF-␤ family of growth factors, mainly activin A and TGF-␤1, have been shown to support the proliferation and multipotency of TS cells in culture (3) . In addition to these exogenous stimuli, experiments using targeted deletion have also revealed a set of transcription factors that are crucial for the establishment and maintenance of TSC population, including Tead4, Cdx2, Eomes, Elf5, Ets2, Gata3, Tcfap2c, Esrr␤, and Sox2 (4 -12) .
In this study we aimed to gain insight into mouse trophoblast genomic identity and lineage specification by identifying genes specific to the TSC compartment. To this end we performed global gene expression profiling on four different cell types: mouse TSCs, mouse embryonic stem cells (ESCs), mouse epiblast stem cells (EpiSCs), and mouse embryonic fibroblasts (MEFs). By comparing differentially expressed genes in these cell lines, we identified a list of genes that are specific to TSCs, including some previously identified such as Cdx2 and Tead4; we hypothesized that these genes may function to maintain TSCs in an uncommitted state and/or initiate their differentiation process.
We further explored the function of one gene in particular, Sox21, in TSC self-renewal and multilineage differentiation. Sox21 belongs to the SoxB2 group of the Sry-related HMG box (SOX) gene family and, based on the analysis of its structural protein domains, has been reported to be a transcriptional repressor (13) . Sox21 has been mostly characterized in the context of neuronal differentiation. Immunohistochemical analysis showed a restricted expression of Sox21 in neurogenic regions of both embryonic and adult mouse brain (14) . Consistently, ectopic expression of Sox21 induced neural progenitor cells to leave the cell cycle and up-regulate neuronal markers, suggesting a critical role for Sox21 in the regulation of neurogenesis (15) . Moreover, overexpression of Sox21 in ES cells appears to trigger differentiation of these cells toward a mesoderm and neuroectoderm phenotype (16) . It is worth noting that in the same study, Sox21 was capable of inducing the expression of two trophectoderm markers, Esx1 and Cdh3. However, the expression and function of Sox21 in extraembryonic tissues, including TSCs, is to date unknown. Our results show that Sox21 is highly expressed in undifferentiated TSCs compared with both embryonic and epiblast stem cells and regulates initiation of differentiation specifically toward the spongiotrophoblast/giant cell lineage. These findings implicate Sox21 as a novel player in trophoblast differentiation and placental development.
Experimental Procedures
Microarray Analysis-All mouse cell lines used in this study were derived from mice with the same genetic background (129S1/SvImJ). TSCs were derived form E3.5 blastocysts according to a previous published protocol (17) . MEFs were derived from E13.5 embryos (18) . EpiSCs were derived from ESCs following the protocol outlined by Zhang et al. (19) . ESCs were a generous gift of Predictive Biology Inc. (Carlsbad, CA).
RNA samples used for microarray analysis were prepared using the TotalPrep kit (Ambion) according to the manufacturer's instructions. Gene expression profiling was performed using MouseRef-8 v2.0 Expression BeadChips according to the manufacturer's instructions (Illumina, San Diego, CA). Each hybridization experiment was performed on a total of five replicates, and the data were normalized after background subtraction.
Global expression profile data were analyzed using Qlucore Omics Explorer (Lund, Sweden). The list of probes for cluster analysis was created in Qlucore comparing each sample group against the others. Statistically significant genes were selected with a variance of 0.01, two-group analysis with q Ͻ 0.05, and a -fold change Ն2.0. Probe clustering was performed with Qlucore using the agglomerative clustering algorithm.
Gene Ontology analysis was performed using the functional annotation tools available in the Database for Annotation, Visualization, and Integrated Discovery (DAVID) v6.7 (20, 21) .
Mouse Cell Culture-TS cells were derived from E3.5 blastocysts of 129S1/SvImJ matings as previously described (17) . TS cells were cultured at 37°C and 5% CO 2 and maintained in RPMI 1640 culture medium (Corning/Cellgro) supplemented with 20% fetal bovine serum, 1 mM sodium pyruvate (Invitrogen), 1ϫ penicillin/streptomycin, 55 nM ␤-mercaptoethanol (Invitrogen), 25 ng/ml fibroblast growth factor 4 (FGF4; Sigma), and 1 g/ml heparin (Sigma) with 70% of medium being conditioned for 72 h on inactivated mouse embryonic fibroblasts. For differentiation conditions, TS cell medium was used as described above without supplementation with FGF4, heparin, and conditioned medium.
TS cells were transfected with Lipofectamine 2000 according to manufacturer's instructions with slight modifications. In brief, TS cells were grown to 80% confluence in 6-well plates and then incubated with the Lipofectamine/DNA complexes overnight. The next day cells were washed with PBS, and new medium was added. After 48 h, cells were treated with the appropriate antibiotic to allow selection of transfected cells. After 2 weeks, the remaining cells were replated and cultured for 2 passages before being frozen for long term storage or used for experiments. For the generation of the Sox21 shRNA stable cell lines, three different constructs were initially tested, but only one showed an efficient knockdown of the Sox21 mRNA.
All the experiments were performed using at least two different stable cell lines carrying the same shRNA construct.
Human Cell Culture-Placental tissues were collected under a protocol approved by the Human Research Protections Program Committee of the University of California San Diego Institutional Review Board. All patients gave informed consent for collection and use of these tissues. First-trimester cytotrophoblasts were isolated from elective terminations between 6 and 12 weeks gestational age as previously described (22) . Cytotrophoblasts were seeded at a density of 300,000 cells/cm2 in 6-well plates coated with 20 g/ml fibronectin. Cells were cultured in trophoblast medium containing Dulbecco's modified Eagle's medium:nutrient mixture F-12 supplemented with 10% fetal bovine serum (Sigma), 2% penicillin/streptomycin, 0.2% gentamicin, and 55 M 2-mercaptoethanol with media changed every other day.
In Situ Hybridization of Placental Implantation Sites-Under an approved animal protocol, timed matings were performed with CD-1 mice, and E6.5, E7.5, and E8.5 implantation sites and E10.5 placentas were harvested and fixed overnight in 4% paraformaldehyde in 1ϫ PBS. The samples were then processed, paraffin-embedded, and sectioned at 5 m. Sections were stained with hematoxylin and eosin to identify the optimal sections for in situ hybridization. In situ hybridization was performed on a Ventana automated stainer using a mouse Sox21specific probe and a negative control probe, both from ACD-Bio.
RNA Preparation, cDNA Synthesis, and Quantitative Realtime PCR-Total RNA from TSC cultures was isolated using the NucleoSpin RNA kit (Clontech). 1.0 g of RNA was reverse-transcribed using the iScript cDNA Synthesis kit in a 20-l reaction. The cDNA was diluted 10 times in nuclease-free water and 2 l of the diluted cDNA along with 625 nM concentrations of each primer and POWER SYBR Green PCR master mix (Applied Biosystems) were used for the PCR reaction. Quantitative real-time PCR (qRT-PCR) reactions were performed in triplicate for each sample using an Eco Real-time PCR System (Illumina) and a one-step program: 95°C for 10 min; 95°C for 30 s and 60°C for 1 min for 40 cycles. A melting curve analysis was arranged for determination of PCR product specificity. For each reaction a cycle threshold (C t ) value was recorded. The mean C t value of triplicate reactions was used to determine the relative gene expression normalized against Gapdh using the comparative C t (⌬⌬C t ) method (23) . For a comprehensive list of primers used in this study please see Table 1 .
Western Blot Analysis-Protein extracts were prepared with a modification of radioimmune precipitation lysis buffer (50 mM Tris/HCl, 150 mM NaCl, 01% (v/v) Nonidet P-40, and 0.1% (w/v) SDS) supplemented with protease and phosphatase inhibitors (Roche Applied Science) according to the manufacturer's protocol. The protein content was determined with the Pierce BCA protein assay kit (Thermo Scientific). A total of 30 g of total protein was separated on a 10% denaturing polyacrylamide gel and electrophoretically transferred to PVDF membranes.
Membranes were blocked with 5% nonfat dried milk in Trisbuffered saline containing 0.1% (v/v) Tween 20 (Sigma) fol-lowed by incubation with the primary antibody. Primary antibodies included goat anti-Sox21 (AF3538, R&D systems), Gcm1 (P100836_P050, Aviva System Biology), and mouse anti-␤-actin (A5441, Sigma).
Immunostaining-TS cells were plated on glass coverslips, fixed in 4% paraformaldehyde in PBS for 15 min, and permeabilized in 0.5% Triton X-100 in PBS for 2 min. Mouse anti-HA tag antibody (ab18181, Abcam), goat anti-Sox21 (AF3538, R&D systems), and Alexa dye-conjugated phalloidin and Alexa Fluor-conjugated secondary antibodies (Invitrogen) were used per the manufacturer's instructions. Coverslips were mounted using Vectashield mounting media containing DAPI (Vector Laboratories). Trophoblast giant cells were identified as cells with large, sometimes bilobed nuclei at least twice the size (judged as estimated cross-sectional area) of undifferentiated TS cell nuclei.
Invasion Assay-For invasion assays, Transwell chambers with 6.5-mm-diameter polycarbonate filters of 8-m pore size (Costar) were placed into wells of a 24-well plate. Each filter was coated with 100 l of a 1:20 dilution of cold Matrigel (BD Bioscience) in RPMI 1640 medium and let to solidify at 37°C for 2 h. Trophoblast stem cells were differentiated for 7 days in TS media; on day 7, cells were trypsinized, and 10 5 cells were plated onto the Matrigel-coated filter. The medium in the lower chamber was changed every day. After 3 days, the Transwell inserts were fixed for 15 min with 4% formaldehyde in PBS and washed with PBS. Cells that remained at the upper surface of the filters were scraped off, and filters were stained with DAPI and phalloidin. The remaining cells (migrated to the bottom of the filter) were imaged and counted using a fluorescence microscope (Leica).
Proliferation and Apoptosis Assays-Proliferation assays were performed by plating 25 ϫ 10 4 cells/well in TS cell medium on a 6-well plate. Cells were collected and counted using an automated cell counter (Bio-Rad) at days 1, 3, 5, 7, and 9, replacing the medium every other day. To assay apoptosis, an annexin V-FITC Apoptosis Detection kit (BD Biosciences, catalog #556547) was used following the manufacturer's instructions.
Statistical Analysis-Unless otherwise stated data presented are the mean Ϯ S.D. of three biological replicates. Student's t test was performed, and p values below 0.05 were taken to indicate a statistically significant difference between the populations sampled.
Results

Genome-wide Expression Profiling of Mouse Stem Cells-
Global expression profiles were obtained from mouse TSCs, ESCs, ESC-derived EpiSCs, and MEFs. Principal component analysis showed clustering of TSC replicates, distinctly separated from ESCs, EpiSCs, and MEFs (Fig. 1A) . The heatmap in Fig. 1B shows genes with statistically significant differences in expression among the different cell types. Hierarchical cluster analysis revealed a cluster of genes specifically up-regulated in TSC, including many previously characterized TSC-specific genes such as Cdx2, Eomes, and Tead4, thus confirming the accuracy of the microarray data ( Fig. 1C ; for a comprehensive list of TSC-specific genes, see supplemental Table 1 ). Gene Ontology analysis of the TSC-specific cluster revealed a total of 85 biological process categories that were significantly overrepresented, including regulation of transcription, embryonic, and placenta development, regulation of cell proliferation, apoptotic process, and intracellular signaling cascade. The top 13 TSC-associated biological process categories are shown in Fig.  1D . We then turned our attention to novel and uncharacterized genes with a Ͼ2-fold expression difference when comparing TSCs with all other cell types. Among these genes was Sox21, a member of the Sox family of transcription factors, with an unknown role in the context of TSCs. To validate the data from the microarray analysis, we analyzed the expression of Sox21 in TSC, ESC, EpiSC, and MEFs by qRT-PCR and Western blot ( Fig. 1 , E and F, respectively). qRT-PCR experiments showed that Sox21 expression was two and five times higher in TSCs compared with ESCs and EpiSCs, respectively. Sox21 mRNA levels in MEFs were low or undetectable. qRT-PCR data were, subsequently, confirmed at the protein level by immunoblotting. Interestingly, microarray data analysis showed that Sox21 was the only member of the family uniquely expressed in TSC, although Sox5, -8, and -13 were also expressed in TSC (data not shown).
Sox21 Expression in the Early Mouse Placenta and during Trophoblast Cell Differentiation-To examine the expression of Sox21 in vivo, we performed in situ hybridization of mouse embryos and placentas at different stages of development. At E6.5, Sox21 was mainly detected in a subset of cells in the extra- 
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embryonic ectoderm ( Fig. 2A ). At E7.5, Sox21 RNA was highly expressed in the chorion but undetected in the ectoplacental cone (Fig. 2, B and C) . At E8.5, Sox21 was detected in some cells in the ectoplacental cone and the TGC layer ( Fig. 2D ). In the E10.5 placenta, Sox21 expression was significantly reduced and was detected only in rare TGCs ( Fig. 2E) .
To determine the subcellular localization of Sox21 in TSCs, we first employed immunocytochemistry using a Sox21-specific antibody. Sox21 was detected in the nuclei of undifferentiated cells, and the staining was strongly reduced in cells with a morphologically differentiated phenotype (Fig. 3A) . We next investigated Sox21 RNA expression pattern by qRT-PCR in TSCs upon withdrawal of FGF4 and heparin (FGF4-H) and conditioned medium (CM) to induce differ-entiation. Under these conditions, TSCs decrease expression of known stem cell markers Cdx2 and Esrrb (Fig. 3B , black and dark gray bars, respectively); the reduction in Sox21 mRNA was more gradual until day 7 when it was undetectable ( Fig. 3B , light gray bar). To confirm the qRT-PCR data, we performed Western blot analysis on whole cell lysates showing that Sox21 protein expression was significantly reduced by day 4 after removal of FGF4-H and CM and completely lost by day 7 (Fig. 3C ). Moreover, immunocytochemistry of TSCs confirmed the reduction of Sox21 nuclear signal during differentiation, showing only a residual signal at day 5 and complete loss of expression by day 7 (Fig. 3D ). Finally, we evaluated the expression of SOX21 in primary human trophoblast. We performed qRT-PCR on human DECEMBER 11, 2015 • VOLUME 290 • NUMBER 50 cytotrophoblast cells isolated from first trimester placentas (Fig. 3E ). SOX21 RNA levels were high in freshly isolated, undifferentiated cells and decreased significantly after 4 days of in vitro differentiation. These data clearly show that in both mouse and human, Sox21 expression is highest in undifferentiated trophoblast and decreases with differentiation.
Sox21 in Trophoblast Stem Cell Differentiation
Gene Silencing of Sox21 Interferes with Spongiotrophoblast and TGC Differentiation-We set out to knockdown Sox21 in TSCs to determine the effect(s) on differentiation. To this end we generated stable cell lines expressing lentiviral Sox21-specific shRNAs and a scramble shRNA as a control. After transfection and selection with puromycin, we analyzed expression levels of Sox21 by qRT-PCR. shRNA designed to knockdown Sox21 mRNA resulted in a significant decrease in Sox21 mRNA, down to 50% compared with control (see Fig. 4D at day 0) . Under growth conditions Sox21 knockdown (Sox21-KD) cells had a similar morphology to scramble control cells (Fig. 4A,  right and left panels, respectively) . The knockdown level of Sox21 was evaluated at the protein level by Western blot during differentiation, showing a decrease in Sox21-KD cells compared with control ( Fig. 4B ). We then analyzed the RNA expression of the stem cell markers, Cdx2, Esrrb, and Eomes, comparing Sox21-KD and control cells. Cdx2 and Esrrb showed similar levels expression, whereas under the same conditions, Eomes was significantly down-regulated ( Fig. 4C ). Sox21-KD and control cells also showed no difference in proliferation or apoptosis (data not shown). Upon differentiation, Sox21-KD cells downregulated Sox21 RNA levels more significantly than the scramble control cells (Fig. 4D) . By contrast, expression of TGC markers placental lactogen-1 (Prl3d1), placental lactogen-2 (Prl3b1), and proliferin (Prl2c2) and the spongiotrophoblast marker Tpbpa were reduced in Sox21-KD when compared with scramble control cells (Fig. 3, E and F) . Moreover, we analyzed . ShRNA-mediated knockdown of Sox21 in TSCs. A, immunocytochemistry of control and Sox21-KD TSCs in growth media (ϩFGF4-H and CM); cells were stained with phalloidin (green) and DAPI (blue). B, Western blot for Sox21 of lysates from Sox21-KD and control cells at the indicated days of differentiation. Actin was used as loading control. C-H, FGF4-H and CM were then removed to induce differentiation, and cells were collected at the indicated time points (days post-differentiation) for qRT-PCR analysis of indicated markers, including stem cell markers (Cdx2, Esrr␤, and Eomes; C), Sox21 (D), TGC markers (Prl3d1, Prl3b1, Ctsq, and Prl2c2; E), spongiotrophoblast marker (Tpbpa; F), labyrinthine progenitor markers (Epcam and Ly6e; G), and other labyrinthine trophoblast markers (Gcm1 and Muc1; H). All data are expressed as -fold change relative to day 0 (D0). * indicates a statistically significant difference (p Ͻ 0.05) compared with scramble control. DECEMBER 11, 2015 • VOLUME 290 • NUMBER 50 JOURNAL OF BIOLOGICAL CHEMISTRY 30157 the expression of two labyrinthine trophoblast progenitor markers, Epcam and Ly6e (24, 25) , and found that both were maintained in differentiating Sox21-KD cells (Fig. 4G ). We also examined RNA expression of Ly6e and the spongiotrophoblast marker Tssc3 at early differentiation time points (within 24 h from removal of feeder conditioned medium and FGF4) and found that they were both significantly up-regulated in Sox21-KD compared with scramble control (data not shown). Finally, during differentiation, labyrinthine markers Gcm1 and Muc1 were more highly up-regulated in Sox21-KD cells compared with the scramble control (Fig. 4H) . These findings suggest that Sox21 knockdown favored induction of the labyrinthine lineage over that of the spongiotrophoblast and TGC lineages. We also analyzed gene expression of several Sox family members, including Sox1, -3, -5, -8, and -13, in Sox21 knock-down cells during differentiation and found that Sox5 and -13 were up-regulated within 24 h of FGF4/feeder conditioned medium removal (data not shown).
Overexpression of Sox21 in TSCs Induces Differentiation toward the Spongiotrophoblast and TGC Lineages-To determine how sustained expression of Sox21 may affect TSC, we next created a stable TSC line where an HA-tagged version of Sox21 was under the control of a CMV promoter. Empty vector (control) and Sox21-HA-transfected TSCs manifested a similar epithelial morphology when cultured under growth conditions (Fig. 5A ). Sox21-HA and control cells showed no difference in proliferation or apoptosis (data not shown). In the presence of FGF4-H and CM, mRNA levels of Sox21 were eight times higher in Sox21-HA compared with control TSCs. During differentiation, Sox21-HA-transfected TSCs down-regulated 
Sox21 to a lesser extent, maintaining an average of 3-fold higher expression of Sox21 throughout differentiation (Fig. 5B) . To better quantify the percentage of Sox21-HA-positive cells, we evaluated the number of such cells during differentiation and found them to progressively decrease as expected (Fig. 5C ). To determine whether Sox21 overexpression maintains TSC proliferation under differentiating conditions, we quantified the percentage of phosphohistone H3 (pHH3)-positive cells among both HA-positive and HA-negative cells in the same subculture. Phosphohistone H3 is a proliferation marker that is specific to late G 2 and the four phases of mitosis (26) . We did not find any significant difference in the percentage of phosphohistone H3-positive cells in Sox21-HA-expressing cells (Fig. 5D ), indicating that Sox21 does not provide any proliferation advantage to mouse TS cells during differentiation.
Under conditions of differentiation, cultures of both control and Sox21-HA TSCs resulted in loss of stem cell markers Cdx2, Esrr␤, and Eomes with no statistically significant differences between the two cell lines (Fig. 5E ). By contrast, levels of TGC markers Prl3d1, Prl3b1, Ctsq, and Prl2c2 (Fig. 5F) were increased by 1.3-2.2-fold in Sox21-HA cells compared with control. We next analyzed the expression of the spongiotrophoblast markers Tpbpa and Ascl2 and found that both genes were ϳ4 times higher in Sox21-HA cells (Fig. 5G, black and gray  bars, respectively) . Interestingly, during early differentiation (within 24 h from removal of feeder conditioned medium and FGF4), RNA expression of Tssc3, an inhibitor of Tpbpa expression, was significantly reduced (data not shown). When we examined the level of transcripts encoding labyrinthine markers Muc1 and Gcm1, both were 2-7-fold lower in Sox21-HA cells (Fig. 5H, black and gray bars, respectively) ; expression of Ly6e was also significantly reduced, although that of Epcam, another labyrinthine progenitor marker, was not significantly altered (data not shown). Gcm1 protein levels were also downregulated in Sox21-HA cells compared with control as showed by Western blot (Fig. 5I ). All together these results suggest that overexpression of Sox21 tilts the balance of differentiation away from labyrinthine and toward the spongiotrophoblast/TGC lineages.
Sustained Expression of Sox21 in Differentiating TSCs Induces Differentiation of Invasive Trophoblast Lineages-Because Sox21 overexpression induced Prl3b1 and Prl2c2, which are markers of the invasive TGC subtypes, we asked whether the functional competence of these cells reflects the alteration in their gene expression. To this end we first evaluated the number of TGCs in cultures of control and Sox21-HA cells after 7 days of differentiation. After staining with phalloidin and DAPI, TGCs are clearly distinguished by the presence of large nuclei (at least double the size of undifferentiated TS cell nuclei) and highly organized stress fibers (27) (Fig. 6A) . The percentage of TGCs was significantly higher (up to 1.9-fold) in Sox21-HA cells compared with control ( Fig. 6B) . To test the function of Sox21-overexpressing cells, we performed a modified Matrigel invasion assay (28) and found that the number of TGCs capable of migrating through Matrigel and crossing the membrane was 2.5-fold higher in Sox21-HA cells (Fig. 6, C and  D) . The ploidy of the differentiated cells, based on propidium iodide incorporation, was determined by flow cytometry anal-ysis and the percentage of polyploid cells (Ͼ4N), indicating the presence of giant cells, was measured ( Fig. 6E) . Cells expressing Sox21-HA showed a 2-fold increase in the number of polyploid cells compared with control. Overall, these results demonstrate that sustained expression of Sox21 results in larger numbers of invasive TGC.
Discussion
In this study we used transcriptome profiling to identify novel TSC-specific genes. We compared TSCs to three different embryonic cells types, namely pre-implantation ESCs, postimplantation EpiSCs, and MEFs. To minimize the effects of genetic variability, we included cells from a single well defined genetic background (129S1/SvImJ). The results of this analysis confirmed previously characterized genes, such as Cdx2, Eomes, and Tead4, as TSC-specific genes. We then turned our attention to novel genes in this category and characterized Sox21 was also identified as one of a, a high mobility group box transcription factor that has been shown to display transcriptional repressor activity (13) . In a previous report (9) where gene expression profiling was similarly employed to better characterize the transcriptome of TSCs, Sox21 was also identified as one of a set of genes defined by the authors as "core trophoblast genes." Nevertheless, to the best of our knowledge, this is the first report that defines a role for Sox21 in the regulation of mouse TSC differentiation.
In vivo, Sox21 mRNA was expressed at higher levels in the extraembryonic ectoderm and chorion of the early post-implantation mouse embryo; these are the compartments that house TSCs. Sox21 mRNA levels decreased with differentiation in the ectoplacental cone and by midgestation were confined to rare TGCs. To explore the role of Sox21 in trophoblast, we analyzed expression of lineage-specific markers upon removal of FGF4-H/CM stimuli in TSCs expressing Sox21-HA or Sox21-specific shRNA. Our data demonstrate that the presence of higher than physiological levels of Sox21 throughout differentiation mediates increased induction of TGC and spongiotrophoblast markers at the RNA level. In accordance with these results, we found that Sox21-overexpressing cells displayed higher numbers of TGC based on morphology and ploidy analysis as well as enhanced invasive behavior. By contrast, labyrinthine markers were significantly reduced, including Gcm1, a gene described as the master regulator of labyrinthine/syncytiotrophoblast differentiation (29) . Conversely, our knockdown experiments showed that even a 50% reduction in Sox21 levels led to maintenance of labyrinthine progenitor markers, Ly6e (25) and Epcam (24) , induced the expression of labyrinthine trophoblast markers Gcm1 and Muc1, and reduced spongiotrophoblast/TGC markers. These results are consistent with the in vivo localization of some Sox21 mRNA to the ectoplacental cone/early TGCs and its complete absence in the labyrinthine layer. These findings also suggest that an imbalance in the physiological expression of Sox21 may induce abnormal differentiation of TSCs, favoring either the spongiotrophoblast/TGC phenotype or the labyrinthine one. This mechanism has been described in TSCs with other transcription factors, including peroxisome proliferator-activated receptor-␥ and Tssc3 (28, 30) , showing that altered expression DECEMBER 11, 2015 • VOLUME 290 • NUMBER 50 of these genes can result in disproportionate lineage-specific differentiation. Gene expression analysis of Tssc3 during early differentiation revealed up-regulation in Sox21-KD cells and down-regulation in Sox21-HA cells, suggesting that an imbalanced differentiation pattern might already be established during early time points, a pattern that is consistent with changes seen at later time points of differentiation. Whether there is cross-talk between Sox21 and peroxisome proliferator-activated receptor-␥ or they act through a single common pathway is not known.
Sox21 in Trophoblast Stem Cell Differentiation
Sox21 has previously been most extensively studied during mouse neurogenesis (15, 31, 32) . Similar to its expression in the TSC system, Sox21 is expressed in neural progenitors but not in post-mitotic, terminally differentiated neurons (15) . In fact, gain and loss of function experiments have indicated that Sox21 regulates neuronal differentiation in a dose-dependent manner, with a threshold level being required for differentiation and a higher expression promoting progenitor maintenance (32) . However, in TSCs, alterations in Sox21 did not appear to affect either the stem cell state or proliferative capacity. Consistently, stable TSC lines expressing ectopic Sox21 or Sox21-specific shRNA could be maintained in culture for several passages without obvious phenotypic changes. This was somewhat surprising, as in two separate studies Sox21 overexpression in mouse ESCs has been linked to down-regulation of Cdx2 (16, 33) . In our study, manipulation of Sox21 expression was associated with insignificant changes in the "stemness" factors Cdx2 and Esrr␤ under growth conditions, although Eomes mRNA was reduced after Sox21 knockdown. This reduction in Eomes mRNA, however, did not appear sufficient to trigger early differentiation; additionally, the converse change in Eomes expression did not occur in Sox21-overexpressing cells. Although this may suggest a role for Sox21 in maintenance of Eomes, additional studies would be required to confirm this, 
including an inducible knockdown system. In the current study, one main limitation was the extremely low transfection efficiency of TSCs, leading to the need for selection of stably transfected cells. This likely led to selection of cells, not only for their antibiotic resistance, but also for clones expressing low levels of shRNA. This in turn may explain why, even in the best conditions, we could only achieve a 50% reduction in Sox21. An inducible knockdown system would likely allow for a larger reduction in gene expression and thus reveal a greater effect on the trophoblast stem cell state. Alternatively, it is possible that Sox21 in fact does not play a significant role in maintenance of the trophoblast stem cell state. This is supported by the fact that Sox21-knock-out (KO) mice survive the embryonic period and are born (36) ; in the setting of TSC-associated genes required for maintenance of the stem cell state (such as Cdx2 and Eomes), knock-out embryos either do not survive implantation (5) or die shortly thereafter (6) and in both cases are unable to give rise to stable TSC lines (5, 6) .
As mentioned above, Sox21 appears to be dispensable for placental development in vivo; in fact, Sox21-KO mice exhibit only cyclic alopecia as the most obvious phenotype (34) . One possibility is a missed mild placental phenotype despite the viability of the offspring. A closer evaluation of embryonic weight and placental histology of Sox21-KO mice might disclose subtle changes, particularly differences in the labyrinthine versus junctional zone development, previously overlooked. Another possibility, however, is functional redundancy among the Sox family of genes: in fact, coexpression of highly related Sox proteins is a common feature during nervous system development (35, 36) . For example, whereas Sox1 and Sox3 have both been implicated in formation and function of the neuroectoderm, individual knock-out of either gene is associated with a normal neuroectoderm. For Sox21, other family members expressed in TSC, particularly those that are up-regulated during Sox21 knockdown such as Sox5 and Sox13, might be able to compensate during placental development.
The exact mechanism by which Sox21 exerts its effect on TSC differentiation remains to be fully elucidated. One of the major proteins through which Sox21 is known to exert its effects is the closely related family member, Sox2 (16, (37) (38) (39) . Sox2-null embryos die soon after implantation and fail to form both epiblast and extraembryonic ectoderm (12) . Complete obliteration of Sox2 mRNA in 2-cell embryos by RNAi inhibits trophectoderm specification and leads to embryonic lethality at the morula stage (40) . In both ESCs and TSCs, Sox2 levels must be maintained within a narrow range to preserve self-renewal and pluripotency/multipotency (41, 42) . Interestingly, Mallanna et al. (16) showed that in ESCs, Sox21 associated with Sox2 and that Sox21 overexpression triggered differentiation, including induction of trophectoderm associated genes Cdh3 and Esx1. We did not see changes in Sox2 mRNA levels in Sox21 knockdown or overexpressing TSCs (data not shown); nevertheless, it is tempting to speculate that in TSCs, similar to ESCs, Sox21 regulates lineage-specific differentiation through modulation of Sox2 transcriptional activity early after FGF4/CM withdrawal.
In conclusion, our findings reveal Sox21 as a novel TSC-associated gene whose expression appears to regulate a delicate balance in differentiation toward different trophoblast lineages. We believe this study highlights the diverse array of genes required for maintenance and differentiation of this extraembryonic compartment, which is so vital to development and growth of the embryo in utero. Future studies will focus on further evaluation of other newly discovered TSC-specific genes in order to better elucidate the development and function of the placenta.
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